PATIENTS POSITIVE FOR EGFR MUTATIONS BENEFIT FROM TYROSINE KINASE INHIBITORS. THIS TEST USES WHOLE BLOOD AS THE SPECIMEN (LIQUID BIOPSY) TO DETECT MUTATIONS IN EXON 19 (E746_A750DEL), EXON 20 (T790M) AND EXON 21 (L858R). T790M MUTATION IS A RESISTANCE MUTATION WHICH BENEFITS FROM THIRD GENERATION TKIS LIKE OSIMERTINIB.
Why book with us?
Free and On Schedule Sample Collection
24/7 Service
Affordable
Quick and Accurate Reports
10 ML WHOLE BLOOD IN 1 STRECK TUBE. SHIP REFRIGERATED. DO NOT FREEZE. CLINICAL HISTORY IS MANDATORY.